Skip to content
PubMed This is a summary of 13 peer-reviewed journal articles Updated
Radiology · Ductal Carcinoma In Situ

How Does DCIS Appear on a Mammogram? Calcifications

At a Glance

On a mammogram, DCIS most often appears as tiny calcium deposits called microcalcifications, but many calcifications are benign and some DCIS is not visible. Their shape and pattern guide whether diagnostic imaging or biopsy is needed.

Ductal carcinoma in situ (DCIS)—often referred to as stage 0 or non-invasive breast cancer—most commonly appears on a mammogram as tiny, bright white specks known as microcalcifications [1]. However, it is important to know that not all DCIS creates calcifications; sometimes it appears as a mass or is not visible on a mammogram at all [1]. Furthermore, most breast calcifications are entirely benign (non-cancerous) [2]. Because imaging alone cannot establish a diagnosis, doctors interpret the specific features of these calcifications to decide if additional imaging and a tissue biopsy are needed [3].

Understanding Breast Calcifications

Calcifications are small deposits of calcium in the breast tissue. They are extremely common and can form due to natural aging, past injuries, or benign breast changes [4]. Radiologists evaluate two main features: the shape of the individual specks (morphology) and how they are arranged across the breast (distribution). These two features are interpreted together; no single shape or pattern can definitively diagnose DCIS [5].

Calcification Shapes (Morphology)

Morphology describes what each individual calcium deposit looks like. Benign calcifications often appear round, punctate (like tiny dots), or coarse [6]. However, certain shapes increase a radiologist’s suspicion:

  • Fine pleomorphic: Tiny spots that vary in size and shape, looking like distinct, irregular grains of salt [6].
  • Fine linear or branching: Thin, irregular, line-like shapes that may branch out. This specific shape is highly suspicious because it suggests the calcifications are forming inside and filling the branching milk ducts [7]. Fine linear calcifications are frequently associated with higher-grade DCIS (where cells look more abnormal under a microscope) and comedonecrosis (areas of dead cells within the duct) [8].

Calcification Patterns (Distribution)

Distribution describes how multiple calcifications are arranged together, which is distinct from their individual shape.

  • Clustered or grouped: A small cluster of calcifications grouped closely together. While this is a common presentation for DCIS [9], clustered calcifications can also be completely benign depending on their individual shape and your medical history [5].
  • Linear distribution: Calcifications arranged in a line (not to be confused with the individual “fine linear” shape), which can indicate they are lining a single milk duct [6].
  • Segmental: Calcifications that spread through a larger, wedge-shaped segment of the breast, mapping out a wider network of ducts [7].

The BI-RADS Score and Diagnostic Imaging

When radiologists read your mammogram, they assign a BI-RADS category to guide the next steps [3]:

  • BI-RADS 0: More imaging is needed to get a clear picture.
  • BI-RADS 3: The findings are probably benign, usually requiring a short-interval follow-up mammogram (often in 6 months).
  • BI-RADS 4 (A, B, or C): The calcifications are suspicious, and a biopsy is typically recommended.
  • BI-RADS 5: The findings are highly suspicious for cancer, and a biopsy is strongly recommended.

If your routine screening shows suspicious calcifications, you will likely need diagnostic mammographic views [10]. These include magnification views (which enlarge a small area to show the exact shape of the calcifications) and spot-compression views (which press on a specific area to spread the tissue and reduce overlap).

Tissue Sampling (Biopsy) and Pathology

Imaging can highlight suspicious areas, but it cannot definitively tell benign changes apart from DCIS or other abnormalities [2]. If your calcifications are assigned a BI-RADS 4 or 5, a core needle biopsy will be recommended to sample the tissue [3].

For calcifications, doctors often prefer an image-guided, vacuum-assisted biopsy, which uses gentle suction to help retrieve enough tissue for testing [11]. The goal of this biopsy is to sample the targeted calcifications, not to surgically remove all of them. During the procedure, the team will usually take a specimen radiograph (an X-ray of the biopsied tissue) to confirm that the targeted calcifications were successfully captured in the sample [3]. They will also leave a tiny metal clip in your breast to mark the exact spot where the biopsy was taken.

The sampled tissue is then sent to a pathologist, who looks under a microscope to see if abnormal cells are present and confined inside the milk ducts (in situ) [12]. It is important to understand that a needle biopsy only tests a small portion of the suspicious area. Sometimes, the core biopsy shows DCIS, but the final surgical excision later reveals more extensive disease or a small area of invasive cancer that the biopsy needle missed [13]. Therefore, your doctor will check for radiologic-pathologic concordance—ensuring the pathology results logically explain what the radiologist saw on the mammogram—to decide if further sampling or surgery is needed [4].

Common questions in this guide

What does DCIS usually look like on a mammogram?
DCIS most often appears as tiny bright white calcium deposits called microcalcifications. It can also appear as a mass or may not be visible, so a mammogram alone cannot confirm or rule out DCIS.
Do breast calcifications mean I have cancer?
No. Most breast calcifications are benign and can occur with aging, prior injury, or other noncancerous changes. Their shape and arrangement help determine whether additional imaging or a biopsy is recommended.
Which calcifications are more concerning for DCIS?
Fine pleomorphic or fine linear and branching calcifications, especially in clustered, linear, or segmental patterns, can be more suspicious. The radiologist considers the full appearance and your medical history; no single shape or pattern proves DCIS.
What does a BI-RADS 4 or 5 result mean for breast calcifications?
BI-RADS 4 means a finding is suspicious and a biopsy is typically recommended, while BI-RADS 5 is highly suspicious and a biopsy is strongly recommended. BI-RADS 0 means more imaging is needed, and BI-RADS 3 usually leads to short-interval follow-up.
Why is a biopsy needed after suspicious breast calcifications?
Imaging can identify an area that needs evaluation but cannot reliably distinguish benign calcifications from DCIS or other abnormalities. An image-guided core or vacuum-assisted biopsy samples tissue so a pathologist can examine it for abnormal cells.
Can a biopsy miss invasive breast cancer or more extensive DCIS?
Yes. A needle biopsy examines only a sample of the suspicious area, so surgical excision may sometimes show more extensive DCIS or a small invasive cancer not captured by the needle. Doctors also assess radiologic-pathologic concordance, meaning whether the biopsy results adequately explain the mammogram, to decide whether more sampling or surgery is needed.

Get notified when new evidence is published on ductal breast carcinoma in situ.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (13)
  1. 1

    Ductal Carcinoma In Situ of the Breast: An Update with Emphasis on Radiological and Morphological Features as Predictive Prognostic Factors.

    Salvatorelli L, Puzzo L, Vecchio GM, et al.

    Cancers 2020; (12(3)) doi:10.3390/cancers12030609.

    PMID: 32155777
  2. 2

    Low-Risk Women with Suspicious Microcalcifications in Mammography-Can an Additional Breast MRI Reduce the Biopsy Rate?

    Pöschke P, Wenkel E, Hack CC, et al.

    Diagnostics (Basel, Switzerland) 2023; (13(6)) doi:10.3390/diagnostics13061197.

    PMID: 36980504
  3. 3

    [Explorations of breast microcalcifications: Guidelines].

    Chamming's F, Chopier J, Mathelin C, Chéreau E

    Journal de gynecologie, obstetrique et biologie de la reproduction 2015; (44(10)):960-9.

    PMID: 26527023
  4. 4

    Clinicopathologic update of calcium oxalate in breast: A 15-year retrospective review.

    Haghayeghi K, Najibi M, Wang H, et al.

    The breast journal 2020; (26(9)):1736-1741 doi:10.1111/tbj.13952.

    PMID: 32564487
  5. 5

    Combined morphology and distribution features for risk stratification in pathology-enriched BI-RADS 4A/4B microcalcifications.

    Zhang S, Dong S, Chen Y, et al.

    BMC cancer 2026; (26(1)).

    PMID: 43009821
  6. 6

    Malignancy Risk Stratification of Suspicious Breast Microcalcifications Detected on Mammograms Using Morphological and Distribution Characteristics Based on the Fifth Edition of BI-RADS.

    Hegde SS, Ananthasivan R, Ramachandra SP

    The Indian journal of radiology & imaging 2026; (36(1)):92-99 doi:10.1055/s-0045-1809161.

    PMID: 41523350
  7. 7

    Mammography of suspicious calcifications among ductal carcinoma in situ and benign breast disease.

    Lohitvisate W, Kaeorat C, Kwankua A

    SA journal of radiology 2024; (28(1)):2852 doi:10.4102/sajr.v28i1.2852.

    PMID: 38840823
  8. 8

    Clinicopathological and prognostic value of calcification morphology descriptors in ductal carcinoma in situ of the breast: a systematic review and meta-analysis.

    van Leeuwen MM, Doyle S, van den Belt-Dusebout AW, et al.

    Insights into imaging 2023; (14(1)):213 doi:10.1186/s13244-023-01529-z.

    PMID: 38051355
  9. 9

    Screen-detected ductal carcinoma in situ found on stereotactic vacuum-assisted biopsy of suspicious microcalcifications without mass: radiological-histological correlation.

    Szynglarewicz B, Kasprzak P, Biecek P, et al.

    Radiology and oncology 2016; (50(2)):145-52 doi:10.1515/raon-2016-0020.

    PMID: 27247546
  10. 10

    Initial experience of magnification tomosynthesis in depiction of suspected microcalcifications: prospective reading study of a novel reconstruction algorithm prototype.

    Arlan K, Meretoja TJ, Hukkinen K

    Acta radiologica (Stockholm, Sweden : 1987) 2025; (66(6)):608-617 doi:10.1177/02841851251317633.

    PMID: 39967302
  11. 11

    Vacuum-assisted breast biopsy vs core needle biopsy: a systematic review and meta-analysis.

    Sharma N, Theis S, Vogelmann T, Pijnappel R

    European radiology 2026; (36(6)):4449-4466 doi:10.1007/s00330-025-12299-1.

    PMID: 41553473
  12. 12

    Identifying progression predictors of breast ductal carcinoma in situ.

    Yeong J, Thike AA, Tan PH, Iqbal J

    Journal of clinical pathology 2017; (70(2)):102-108 doi:10.1136/jclinpath-2016-204154.

    PMID: 27864452
  13. 13

    A Validated Nomogram to Predict Upstaging of Ductal Carcinoma in Situ to Invasive Disease.

    Jakub JW, Murphy BL, Gonzalez AB, et al.

    Annals of surgical oncology 2017; (24(10)):2915-2924 doi:10.1245/s10434-017-5927-y.

    PMID: 28766196

This page is for informational purposes only and does not constitute medical advice. Your radiologist and care team should interpret your mammogram and pathology results and recommend next steps.